For 18 years, Kaiser Permanente has supported USS Midway Museum services, education programs, and exhibits through marketing partnerships. In 2022, Midway’s first marketing partner continues its support as a naming rights sponsor of Midway University classroom #4, exclusive presenting sponsor of ship’s Sick Bay and Battle Dressing Station exhibits, and as a presenting sponsor of museum’s STEM education onboard field trip programs.

In the second year of our two-year partnership, Kaiser Permanente also continues as Commander sponsor of the Midway American Patriot Award Gala and sponsor of Midway’s “I Served” program that gives veterans onboard Midway the recognition for their service that they deserve.

“The Midway Museum is an invaluable asset to San Diego, and has been instrumental in building a stronger, healthier community for us all,” said Rodger Dougherty, senior director of public affairs and communications for Kaiser Permanente San Diego. “Kaiser Permanente is honored to continue our long-standing partnership with the Midway, in support of the museum’s mission to preserve the historic ship, honor the legacy of those who serve, educate and inspire future generations, and entertain the many visitors the museum hosts each year.”

“Midway continues to deliver quality STEM education programs for students and inspiring programs for Midway visitors and those who serve in part because of Kaiser Permanente’s generous support,” said Craig Fisher, Midway’s director of partnership marketing. “We are so grateful for their partnership and their commitment to Midway and the San Diego community.”

The organization that is now Kaiser Permanente began at the height of the Great Depression with an inventive young surgeon and a 12-bed hospital in the middle of the Mojave Desert. Today, Kaiser Permanente health plan membership is more than twelve million members in eight states and the District of Columbia. Locally, Kaiser Permanente cares for nearly one in five (more than 630,000) San Diegans and continues to grow every day.

Comments are closed.